Shenzhen Kangtai Biological Products Co., Ltd. (SHE: 300601)

China flag China · Delayed Price · Currency is CNY
17.73
-0.02 (-0.11%)
Dec 30, 2024, 3:04 PM CST
-34.70%
Market Cap 19.16B
Revenue (ttm) 3.03B
Net Income (ttm) 515.35M
Shares Out 1.12B
EPS (ttm) 0.46
PE Ratio 37.43
Forward PE 20.24
Dividend 0.40 (2.33%)
Ex-Dividend Date n/a
Volume 5,723,630
Open 17.63
Previous Close 17.75
Day's Range 17.56 - 17.84
52-Week Range 12.93 - 27.35
Beta 0.93
Analysts n/a
Price Target n/a
Earnings Date Apr 21, 2025

About Shenzhen Kangtai Biological Products

Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China. Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines. The company’... [Read more]

Sector Healthcare
Founded 1992
Employees 1,902
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300601
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.